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SAP Review - Regimen Selection
Clinical Outcomes Clinical Outcomes (continued)
• Institutional Review Board (IRB)-approved 
• Electronic health record (EHR)-based retrospective and 
prospective analysis of hysterectomy and colorectal 
surgeries performed at a tertiary medical center 
• Study population:
• Patients ≥ 18 years old
• Underwent a hysterectomy or 
colorectal surgery
• Study period:
• Pre-intervention: October 2019-March 
2020
• Post intervention: July-December 2020
• April-June 2020 was excluded due to 
the COVID-19 pandemic
• Exclusion criteria:
• Underwent greater than one type of 
surgery 
• All patients meeting inclusion criteria were included
• Primary outcomes: overall compliance of SAP and the 
percent change from the pre- to post-intervention 
analysis phase
Patient Population
• A total of 276 patients who underwent a hysterectomy were 
included in the pre-intervention analysis (October 2019-
March 2020) and 244 patients were included in the post-
intervention analysis (July-December 2020).  
• For colorectal surgeries, 170 patients were included in the 
pre-intervention analysis and 193 patients were included in 
the post-intervention analysis. 
Clinical Outcomes
Hysterectomy SAP 
• 35% achieved the primary outcome of compliance to the 
system guidelines in the pre-intervention analysis.
• 71.6% achieved the primary outcome of compliance to the 
system guidelines in the post-intervention analysis.
• Overall, there was a 105% change in SAP selection for 
hysterectomy surgeries to the guideline recommended 
regimen (cefazolin only to cefazolin plus metronidazole).
Colorectal SAP
• 75.8% achieved the primary outcome of compliance to the 
institutional guidelines in the pre-intervention analysis 
(cefazolin or ceftriaxone plus metronidazole).
• 80.5% achieved the primary outcome of compliance to the 
institutional guidelines in the post-intervention analysis.
• Overall, there was a 752% change in SAP selection for 
colorectal surgeries to the institutional preferred regimen 
(cefazolin to ceftriaxone).
SSI Occurrence
• No SSIs occurred in October-December 2019 for either 
procedure.
• Four SSIs occurred in January-March 2020 for colorectal 
surgeries. All cases included cefazolin plus metronidazole.
• Two SSIs occurred in July-December 2020 for colorectal 
surgeries. Both cases included ceftriaxone plus 
metronidazole. 
• One SSI occurred after a hysterectomy in August 2020 using 
the regimen cefazolin plus metronidazole.
Study Limitations
• Retrospective, non-randomized study
• Select data was pulled from EHR via retrospective chart 
evaluation by single reviewer
• Could not include April-June 2020 data due to the absence of 
elective surgeries during the start of the COVID-19 pandemic
• Did not assess patients with a history of MRSA who should 
have received vancomycin pre-operatively
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• Surgical site infections (SSIs) are a significant cause of 
morbidity, prolonged hospitalization, and mortality.
• Studies estimate SSIs contribute to nearly one million 
additional inpatient days per year and SSI mortality 
rate has been estimated to be 3%.
• Additionally, SSIs in the US alone have an annual cost 
of approximately $3.5 billion.
• A prior quality improvement project performed at a 
large, tertiary medical center in 2018-2019 identified 
that consistent adherence to the system surgical 
antibiotic prophylaxis (SAP) guideline and institutional 
antibiogram for antibiotic selection was an area for 
improvement.
• This was particularly evident in hysterectomy and 
colorectal surgeries; therefore, the institutional SSI 
committee implemented quality improvement changes 
in July 2020.
• For hysterectomies, the committee recommended 
adding metronidazole to cefazolin. 
• For colorectal surgeries, the preferred agent was 
changed from cefazolin plus metronidazole to 
ceftriaxone plus metronidazole. 
• This study was performed to assess hysterectomy and 
colorectal surgery peri-operative antibiotic prophylaxis for 
compliance from previous recommendations made by the 
institutional SSI committee and measure the percent change 
from the pre-intervention analysis.
• The rate of change to the recommended SAP was 105% and 
752% for hysterectomy and colorectal surgeries, respectively.
• There was a higher rate of error associated with the use of 
cefazolin in colorectal surgeries.
• The rate of incorrect use of an alternative regimen for a 
beta-lactam allergy in hysterectomies decreased from 2.6% 
to 1.6%  (pre- and post-intervention, respectively).
• The rate of incorrect use of an alternative regimen for a 
beta-lactam allergy in colorectal surgeries decreased from 
2.4% to 2% (pre- and post-intervention, respectively).
• Four SSIs occurred in the pre-intervention phase compared 
to two SSIs in the post-intervention phase in colorectal 
surgeries. However, it is difficult to assess if antibiotic 
selection was the main cause of infection, as there were 
many other variables to consider. 
• Individual provider data was collected and shared internally 
for the purpose of quality improvement. 
• Additional statistical analysis is currently being assessed. 
Purpose
• To evaluate the overall compliance of SAP selection 
prior to incision based on guideline recommendations 
from the institutional SSI committee
Methodology
• Assess hysterectomy and colorectal surgery peri-
operative antibiotic prophylaxis for compliance from 
previous recommendations made by the institutional 
SSI committee
• Measure the percent change of primary surgeon and 
anesthesiologist SAP selection from the pre-
intervention analysis phase to post-intervention 
analysis phase 
Results
Table 1. Institution Recommendations for SAP in Adults
Table 3. Incorrect Dose of Antibiotic Given in Hysterectomy 
and Colorectal Surgeries
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Figure 1. Hysterectomy SAP Regimen Percent Use
Figure 2. Colorectal SAP Regimen Percent Use











Incorrect timing prior 
to surgery 3 2 1 6 7.5
Re-dose needed 1 2 1 4 5.0
Incorrect timing of re-
dose/ re-dose not 
needed
1 1 2 2.5
Incorrect dose 
amount given 4 7 7 9 27 33.8
No abx given 6 8 5 11 30 37.5
No true BLA 4 3 2 2 11 13.8
No true MRSA hx 0
n=80 (number of incidences of error); Q= quarter
Table 5. Percent of Errors Associated with Antibiotic Use in 
Colorectal Surgeries











Incorrect timing prior 
to surgery 7 4 7 4 22 20.6
Re-dose needed 8 6 8 2 24 22.4
Incorrect timing of re-
dose/ re-dose not 
needed
8 5 1 14 13.1
Incorrect dose 
amount given 5 8 5 3 21 19.6
No abx given 2 4 3 7 16 15.0
No true B-lactam 
allergy 2 2 1 3 8 7.5
No true MRSA hx 1 1 2 1.9
















PERCENT OF ANTIBIOTIC USE FOR COLORECTAL SAP
















PERCENT OF ANTIBIOTIC USE FOR HYSTERECTOMY SAP
CEF+MET CEF ONLY Incorrect abx regimens Correct abx use for BLA
Table 4. Percent of Errors Associated with Antibiotic Use in 
Hysterectomy Surgeries
Hysterectomy Incorrect Dose Amount # Instances
< 5mg/kg gentamicin 2
>120kg received cefazolin 2gm 6
<120kg received cefazolin 3gm 8
<120kg received cefazolin 1gm 10
<120kg received ceftriaxone 1gm 1
TOTAL 27
Colorectal Incorrect Dose Amount # Instances
>120kg received cefazolin 2gm 3
<120kg received cefazolin 1gm 11
<120kg received clindamycin 600mg 1
<120kg received levofloxacin 500mg 2
<120kg received ceftriaxone 1gm 4
TOTAL 21


















Hx= history; CFTX= ceftriaxone; CEF= cefazolin; MET= metronidazole; VANC= 
vancomycin; GM= gentamicin; BLA= B-lactam allergy; CLDM= clindamycin; 
MRSA=Methicillin-resistant Staph. Aureus; abx= antibiotics
Hysterectomy with Cefazolin Percent Error (%, n=80)
Cefazolin + metronidazole 35
Cefazolin only 7.5
Colorectal with Cefazolin or 
Ceftriaxone Percent Error (%, n=107)
Cefazolin + metronidazole 53.3
Ceftriaxone + metronidazole 2.8
Table 2. Percent of Errors Associated with the Recommended 
Regimens
